BridgeMD
New treatment option for Neuroendocrine Tumor
Official title 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
ClinicalTrials.gov ID: NCT05069220
What this study is testing
What is 18F-MFBG?
18F-MFBG is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for neuroendocrine tumor.
Also referred to as 18F-metafluorobenzylguanidine.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with neuroendocrine tumors mainly in pheochromocytoma and paraganglioma (PPGL) and neuroblastoma (NB).
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 80
You may be able to join if
- \- The subject has read, signed, and dated an informed consent form (ICF) prior to any study procedures being performed. Patients with histologically...
- For patients with neuroblastoma, subject should have a routine clinical 123I-MIBG scintigraphy (planar + SPECT/CT) performed within 6 months prior to...
- The subject is male or is a nonpregnant, nonlactating female who is either surgically sterile or is post-menopausal. The subject is able and willing...
You likely can't join if
- \- Patients are potentially pregnant (serum and urinary hCG test will be performed in women where pregnancy is not excluded) or is breast-feeding.
- Patients undergo surgery between the selection and inclusion visit. Patients who are pregnant, may possibly be pregnant, or wish (including their...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Dongcheng, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Dongcheng, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.